N-(4-Hydroxyphenyl)retinamide (4HPR) is currently used in cancer prevention and therapy trials. It is thought that its eects result from induction of apoptosis. 4HPR-induced apoptosis in human cervical carcinoma C33A cells involves enhanced generation of reactive oxygen species (ROS). In this study we explored the mechanism by which 4HPR increases ROS and induces apoptosis in these cells. 4HPR induced cytochrome c release from mitochondria to cytoplasm, activated caspase-3, and caused a membrane permeability transition (MPT). All these 4HPR's eects, as well as the induction of apoptosis, were inhibited by antioxidants, which decrease ROS. Thenoyltri¯uoroacetone, a mitochondrial respiratory chain (MRC) complex II inhibitor, and carbonylcyanide m-chlorophenyl hydrazone, which uncouples electron transfer and ATP synthesis and inhibits ROS generation by MRC, inhibited 4HPR-induced ROS generation very eectively. Rotenone, an MRC complex I inhibitor was less eective and azide, an MRC complex IV inhibitor, exhibited a marginal eect. In contrast, antimycin A, an MRC complex III inhibitor, enhanced 4HPR-induced ROS generation. These ®ndings suggest that 4HPR enhances ROS generation by aecting a target between complex II and complex III, presumably coenzyme Q. This eect is followed by release of cytochrome c, increased caspase-3 activity, induction of MPT and eventual DNA fragmentation and cell death.
Introduction
The synthetic retinoid N-(4-hydroxyphenyl)retinamide (4HPR) was reported to inhibit carcinogenesis in animal models for various epithelial cancers and to exhibit some activity in preneoplastic oral leukoplakia patients and in patients at risk to develop ovarian cancer. Various clinical chemoprevention trials targeting breast, prostate, cervix, skin, bladder, and lung are ongoing. In addition, 4HPR exhibited therapeutic eects indicated by tumor regression in animals bearing carcinogen-induced or xenotransplanted human tumors (Formelli et al., 1996) .
The ability of 4HPR to induce apoptosis in a variety of tumor cell types has led to the suggestion that this activity may be important for its chemopreventive and therapeutic eects (Lotan, 1995; Oridate et al., 1995 Oridate et al., , 1996 Zou et al., 1998) . Recently, Delia et al. (1997) and our group (Oridate et al., 1997) have demonstrated that 4HPR increases ROS generation in leukemia and cervical carcinoma cells, respectively. We suggested that enhancement of ROS generation may be involved in the apoptotic pathway induced by 4HPR.
The major sources of ROS are the mitochondrial respiratory chain (MRC) components (Richter and Schweizer, 1997) and the radical-generating enzymes xanthine/xanthine oxidase (McCord, 1985) and NADPH oxidase (Trudel et al., 1991) . Phospholipase A 2 -activated arachidonic acid metabolism can also be a source of ROS (Henderson et al., 1989) . Apoptosis may occur when the amount of ROS produced in the mitochondria cannot be handled by radical-scavenging cellular antioxidants (Lennon et al., 1991) . Treatment with speci®c MRC inhibitors (Wolvetang et al., 1994) can cause oxidative stress and induce apoptosis. The mechanism of ROS-induced apoptosis appears to involve the release of cytochrome c from mitochondria and its interaction with cytosolic factors including Apaf-1 and dATP to activate caspase-9 and then caspase-3 Green and Reed, 1998; Li et al., 1997; Liu et al., 1996; Martin et al., 1995) .
The present study was designed to explore the mechanism by which 4HPR increases ROS and induces apoptosis in C33A cervical carcinoma cells.
Results

Treatment of C33A cells with 4HPR results primarily in apoptosis with little necrosis
To determine whether 4HPR induced necrosis in addition to apoptosis, we used a method that allows one to detect concurrently viable, necrotic, early apoptotic and late apoptotic cells based on distinct staining patterns by the combination of propidium iodide and Hoechst 33342 (Ormerod et al., 1993; Shimizu et al., 1996) . Treatment of C33A cells with 10 mM 4HPR for 24 h resulted in a decrease in the proportion of viable cells from 92 to 18% with a concurrent increase in necrotic cells from 1.5 to 14% and late apoptotic cells from 2 to 64% (Figure 1) . Thus, the primary eect of 4HPR on C33A cells is induction of apoptosis rather than necrosis. Because we combined the attached and¯oating cells for the analysis, we could not determine whether these subpopulations contained dierent proportions of apoptotic and necrotic cells.
Eects of PDTC and catalase on 4HPR-induced DNA fragmentation in C33A cells 4HPR-induced apoptosis was inhibited by the antioxidant PDTC (Figure 2a ). Catalase also protected cells from 4HPR-induced apoptosis; the increase in DNA solubilization from 9.9% in controls to 21.1% in cells treated with 10 mM 4HPR for 16 h was completely inhibited by catalase (2 mg/ml) (9.9% DNA solubilized in cells treated with DMSO plus catalase and 8.1% in cells treated with 4HPR plus catalase). The eect of catalase and PDTC indicated that H 2 O 2 was produced in 4HPR-treated cells and could be involved in 4HPR-induced apoptosis.
Eects of 4HPR and PDTC on several events associated with programmed cell death 4HPR (10 mM, 12 h) induced the release of cytochrome c from mitochondria in C33A cells as revealed by Western blotting analysis (Figure 3 ). This release was inhibited by PDTC (50 mM), which alone did not induce cytochrome c release in this cell line (data not shown). Thus, 4HPR-induced ROS generation is located upstream of cytochrome c release from mitochondria. A lower concentration of 4HPR (3 mM) was much less eective than 10 mM and the natural retinoid, all-trans-retinoic acid (10 mM) failed to release cytochrome c from mitochondria ( Figure 3 ).
To determine whether 4HPR-induced ROS activate caspase-3-like protease in C33A cells, lysates prepared from cells grown without or with 4HPR were analysed for caspase-3-like protease. Figure 4a shows that treatment with 5 or 10 mM 4HPR increased caspase-3 activity 5 ± 6-fold and Figure 4b shows the cleavage of the 32-kDa caspase-3 precursor, which con®rms the activation of caspase-3. The activation of caspase-3 by 4HPR was inhibited by PDTC (Figure 2b ), suggesting that ROS are indeed involved in caspase-3 activation.
A reduction in mitochondrial transmembrane potential is believed to be mediated by the opening Figure 1 Eect of 4HPR on the modes of cell death in C33A cells. The cells were incubated in control medium or in medium supplemented with 10 mm 4HPR for 24 h. The cells were then stained with PI and Hoechst 33342 and analysed under ā uorescence microscope as described in Materials and methods. The percentage of cells in each of the four indicated categories was determined after analysis of at least 300 cells in several microscopic ®elds Figure 2 (a) Eects of PDTC on 4HPR-induced apoptosis in human cervical carcinoma C33A cells. The cells prelabeled with tritiated thymidine were incubated for 13 h in medium containing DMSO (control) or 4HPR (10 mM) in the absence or presence of PDTC (50 mM). DNA solubilization was analysed as described in Materials and methods. (b) Eects of PDTC on 4HPR-induced caspase-3-like protease activity in human cervical carcinoma. Cells were incubated for 16 h at 378C without (control) or with 4HPR (10 mM) and without or with PDTC (50 mM). Caspase-3-like protease activity was measured as described in Materials and methods. Each assay was performed in triplicate and the results are shown as the mean+s.e.m. Fl.U.=¯uorescence units Figure 3 Eects of PDTC on 4HPR-induced cytochrome c release in human cervical carcinoma C33A cells. The cells were incubated without (control) or with 4HPR (3 or 10 mM) or ATRA (10 mM) and without or with PDTC (50 mM) for 12 h at 378C. Cytochrome c release was analysed by Western blotting using 20 mg cytosolic extract protein per lane as described in Materials and methods. PDTC alone did not induce cytochrome c release in this cell line (data not shown) of the mitochondrial permeability transition (MPT) pore, a multi-protein complex (Zoratti and Szabo, 1995) . Induction of MPT can be estimated by detecting mitochondrial transmembrane potential using a fluorescent probe (Zamzami et al., 1996) . Initially, we wanted to determine whether the membrane potentialsensitive¯uorescent dye DiOC 6 can detect mitochondrial transmembrane depolarization in the C33A cells. Therefore, the cells were treated with the mitochondrial uncoupling agent CCCP (50 mM). After 15 min, thē uorescence intensity peak observed in untreated cells given DiOC 6 was completely shifted to weaker uorescence intensity, indicating that MPT was induced (data not shown). Treatment of the cells with 10 mM 4HPR for 4 h induced MPT as evidenced by a shift of¯uorescence of the probe DiOC 6 from 9.1% in the low¯uorescence fraction in control cells to 65.1% in 4HPR-treated cells (Figure 5a ). This shift was timedependent and was ®rst observed after 6 h of treatment and increased linearly up to 24 h (Figure 5b ). After a 16 h-treatment, the induction of MPT was dosedependent in the range between 1 and 10 mM 4HPR (Figure 5c ). 4HPR-induced MPT was inhibited partially by PDTC ( Figure 5a ). These results show that 4HPR induces MPT in an antioxidant-sensitive pathway and indicate that 4HPR-induced ROS generation is required for MPT induction.
Eects of radical-producing enzyme inhibitors on 4HPR-induced ROS generation in C33A cells
To attempt to identify the site at which 4HPR acts to increase ROS, we analysed the eects of various ROS generation inhibitors. DPI, allopurinol, and quinacrine, the inhibitors of NADPH oxidase, xanthine/xanthine oxidase, and phospholipase A 2 , respectively, failed to inhibit ROS generation induced by 4HPR and have even stimulated the eect of 4HPR compared to control cells (Figure 6a ). These results excluded the above radical-producing systems as being the source of 4HPR-induced ROS. In contrast, the general antioxidants PDTC and NDGA, which were used as positive controls, did suppress 4HPR-induced ROS generation ( Figure 6a ).
Eects of MRC inhibitors and uncoupler on 4HPR-induced ROS generation
Treatment of the C33A cells with CCCP (10 mM), which uncouples electron transfer and ATP synthesis in mitochondria and inhibits the generation of ROS from MRC (Skulachev, 1996) , inhibited nearly completely 4HPR-induced ROS generation (Figure 6b ). These results demonstrated that MRC is the target of 4HPR eects on ROS generation.
We next analysed the eects of several inhibitors of MRC complexes I ± IV on ROS generation using inhibitor concentrations equal to or higher than those reported by others to inhibit the respective complexes in other cell types (Kruidering et al., 1997) . The MRC 3, 6, 9, 12, 15, 18, 21, 24 h and induction of MPT was detected as above. (c) C33A cells were incubated without or with 4HPR at 0.6, 1.2, 2.5, 5, 10 mM for 16 h and suppression of transmembrane potential was detected and evaluated as described above. M1 shows the range of lower¯uorescence representing the loss of membrane potential complex I inhibitor rotenone (40 mM) inhibited 4HPR-induced ROS generation by 40%, whereas the complex II inhibitor TTFA (1 mM) inhibited 4HPR-stimulated ROS generation almost completely (97%) while exerting only a slight eect on the constitutive generation of ROS (Figure 6b) . Treatment of the C33A cells with the complex III inhibitor antimycin A, enhanced 4HPR-induced ROS generation by about twofold, whereas the complex IV inhibitor azide (1 mM) inhibited 4HPR-induced ROS generation by 22%. These results indicated that the main target site of 4HPR is located`downstream' of MRC complexes I and II and`upstream' of complexes III and IV, possibly at the coenzyme Q site of MRC. However, it is also possible that the site is cytochrome b because antimycin blocks the step between cyt. b and cyt. c1 (Figure 7) .
Discussion
Recent studies have demonstrated that 4HPR-induced apoptosis in several leukemia and carcinoma cell lines involves ROS induction (Delia et al., 1997; Oridate et al., 1997; Sun et al., 1999) . The present investigation addressed the mechanism by which 4HPR induces ROS generation and apoptosis. We found that not only the antioxidant PDTC but also catalase inhibited 4HPR-induced apoptosis. These ®ndings lend further support for the conclusion that ROS, and especially H 2 O 2 , are formed in 4HPR-treated cells and are involved in 4HPR-induced apoptosis. The pro-oxidant eects of 4HPR are distinct from the reported ability of the natural retinoic acid, 13-cis-retinoic acid, to act as a scavenger of ionizing radiation-induced ROS (Sanford et al., 1992) .
The inability of inhibitors of xanthine/xanthine oxidase, NADPH oxidase, and phospholipase A 2 to suppress 4HPR-induced ROS generation excluded these radical-producing systems from being major sources of 4HPR-induced ROS in C33A cells. These results have left the mitochondrion as a potential source of 4HPR-induced ROS. The mitochondria are the richest source of ROS because about 1 ± 2% of the oxygen metabolized by mitochondria is converted to O 2 7 by several components of the MRC (Richter and Schweizer, 1997) . O 2 7 is produced in the respiratory chain by complex I (NADH dehydrogenase complex, which has an iron-sulfur center) and reduced coenzyme Q (CoQ, also called ubiquinone) (Figure 7 ) (Richter and Schweizer, 1997) . However, cytochrome b in complex III (ubiquinol:cytochrome c oxidoreductase or cytochrome bc 1 complex) (Nohl, 1987; Nohl and Jordan, 1986 ) may also be involved in ROS generation.
The respiratory chain can be blocked at various sites by speci®c inhibitors. In the presence of respiratory substrates and oxygen, components`upstream' or downstream' of an inhibitor are reduced or oxidized, respectively and O 2 7 is produced by autoxidation of the reduced components of the respiratory chain (Richter and Schweizer, 1997) . Thus, by using various inhibitors, the target sites of ROS generation in mitochondria have been characterized in several systems (Dawson et al., 1993; Garcia-Ruiz et al., 1997; Schulze-Ostho et al., 1992; Taylor et al., 1995; Turrens et al., 1985) .
In this study, the complex II inhibitor TTFA was much more potent than the complex I inhibitor rotenone in suppressing 4HPR-induced ROS generation, suggesting that electron¯ow from complex II to CoQ of the respiratory chain (Figure 7 ) is more important for 4HPR action in the C33A cells than electron entry from complex I to CoQ. Alternatively, the dierence between the ecacy of the complex I and II inhibitors may be due to the fact that electrons channeled through complex II produce about four times more superoxide than those channeled through complex I (Forman and Boveris, 1982; Higuchi et al., 1998) .
Inhibition of the electron transport`downstream' of the CoQ pool by the complex III inhibitor antimycin A, enhanced 4HPR-induced ROS generation, and azide, a complex IV inhibitor (Dawson et al., 1993; Schulze-Ostho et al., 1992; Taylor et al., 1995) , exerted only a minor, though reproducible eect on ; after 3 days, they were treated with DCFH-DA without (DMSO) or with 10 mM of 4HPR and without or with antioxidants (100 mM PDTC, 5 mM NDGA), or inhibitors of radical-producing enzymes (2 mM of DPI, 1 mM of Allopurinol, and 10 mM of Quinacrine). The rate of ROS generation was measured as described in the Materials and methods. (b) The cells were treated without or with 4HPR and without or with the MRC inhibitors Rotenone (40 mM), TTFA (1 mM), Antimycin A (2 mg/ml), sodium azide (1 mM), and the uncoupler CCCP (10 mM) and then ROS generation was determined. Fl.U.=¯uorescence units. The results are presented as the mean+s.d. of triplicate wells 4HPR-induced ROS generation. These observations point to a target site of 4HPR action in ROS generation between complexes II and III. The semiquinone form of CoQ is known to be the major auto-oxidizable electron transport chain component yielding the superoxide radical (Beyer, 1992) . In addition, cyt. b is also involved in ROS generation. Thus, our results suggest that 4HPR activates ROS generation in mitochondria at the CoQ site or cyt. b site or both. The precise mechanism by which 4HPR increases ROS generation at this site remains to be elucidated and is out of the scope of this investigation. Likewise, additional studies are required to determine whether the 4HPR-induced increase in ROS in leukemia cells (Delia et al., 1997) and head and neck and lung carcinoma cells (Sun et al., 1999) are mediated by mitochondrial CoQ or cyt. B sites.
The phosphorylation of ADP to form ATP in the mitochondria (the so-called State 3-State 4 transition) is accompanied by [O 2 ] increase in mitochondria, increase of reduced electron carriers, such as¯avins, CoQ, cytochrome b and non-heme iron proteins, and prolonged life of CoQ 7 (partially reduced form of CoQ, also called ubisemiquinone). We used the uncoupler proton ionophore CCCP because it caǹ short-circuit' the proton current so that both the proton gradient and membrane potential across the inner mitochondrial membrane collapse. Consequently, no phosphorylation of ADP can take place (Bezkorovainy and Rafelson, 1996) and reduction of O 2 is prevented (Skulachev, 1996) . Therefore, State 4-State 3 transition in the presence of uncoupler inhibits ROS accumulation. Thus, our ®nding that CCCP inhibits ROS formation induced by 4HPR strongly supports the conclusion that 4HPR act as a pro-oxidant via mitochondrial respiratory chain, at least in the C33A cells. Higuchi et al. (1997) showed that mitochondrial respiration is necessary for the induction of apoptosis by physiological stimulants such as tumor necrosis factor (TNF), anti-Fas, and by serum starvation using several respiration-de®cient cells or respiration reconstituted clones. They also demonstrated that activation of caspase-3, which is a member of the ICE family of cysteine proteases, depends on mitochondrial respiratory activity. Recently, caspase-3 has emerged as one of the key proteases in spontaneous (Nicholson et al., 1995) , anti-Fas-mediated (Schlegel et al., 1996) , and staurosporine-mediated (Jacobson et al., 1996) apoptosis.
A linkage between mitochondria and caspase-3 activation has been established recently (reviewed in Green and Reed, 1998) . Several groups have shown in a cell-free apoptosis system that cytochrome c was released from mitochondria during induction of apoptosis. Then, together with other factors of cytosolic origin including Apaf-1 and dATP, it activates caspase-9 (Apaf-3), which in turn activates caspase-3 (Li et al., 1997; Liu et al., 1996; Martin et al., 1995) . Other studies have shown that the antiapoptotic proto-oncogene Bcl-2 that is present in mitochondrial membranes can prevent cytochrome c release. This eect was localized upstream of induction of mitochondrial permeability transition, which is assumed to result from the opening of a`pore' in the inner mitochondrial membrane (Kluck et al., 1997; Marchetti et al., 1996b; Yang et al., 1997; Zamzami et al., 1996) . Such a pore can be induced by oxidizing agents, thiol reagents, fatty acids, adenine translocator ligands, and other factors (reviewed in Zoratti and Szabo, 1995) . We evaluated MPT induction by the decrease in DiOC 6¯u orescence level, which detects mitochondrial transmembrane potential (Delta psi). We found that 4HPR induced MPT and that this induction was partially blocked by an antioxidant, suggesting that it is induced by ROS. MPT has been associated with apoptosis although its precise role in this process is somewhat controversial. For example, Marchetti et al. (1996a) showed that MPT precedes a number of apoptotic phenomena and highlighted MPT as being a central coordinating event in apoptosis. More recently, it has been shown that Bcl-2 maintains Delta psi by enhancing H + eux in the presence of agents that induce Delta psi loss and thereby exerts its anti-apoptotic eects (Shimizu et al., 1998) . A question was raised about the requirement of MPT for apoptosis by recent reports, which demonstrated that MPT occurs later than cytochrome c release from mitochondria and caspase activation (Bossy-Wetzel et al., 1998; Higuchi et al., 1998) .
In conclusion, we have demonstrated that 4HPR acts as a pro-oxidant in cervical cancer cell line C33A and located the site of enhanced ROS generation between MRC complexes II and III (probably CoQ site). Further, we have shown that 4HPR induced cytochrome c release, caspase-3 activation, and MPT and that all of these events occurred later than ROS generation and were suppressed by the antioxidant PDTC. It is possible that, in 4HPR-treated cells, ROS derived from MRC aect the mitochondrial membrane such that cytochrome c is released into the cytosol and, consequently, caspase-3-like protease is activated and leads to execution of terminal events of apoptosis (Green and Reed, 1998; Higuchi et al., 1998) . However, further studies are required to determine how 4HPR increases the generation of ROS in the mitochondria and whether the eect of 4HPR on MPT is required for apoptosis induction or not.
Materials and methods
Retinoid
4HPR was obtained from Dr Ronald Lubet (Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, MD, USA). The retinoid was dissolved in dimethyl sulfoxide (DMSO) at a concentration of 10 mM and stored under a nitrogen atmosphere at 7208C.
Cell culture
The human cervical carcinoma cell line C33A was purchased from the American Type Culture Collection (Rockville, MD, USA). The cells were maintained in a 1 : 1 mixture of Dulbecco's modi®ed Eagle's medium : Ham's F12 (DMEM:F12) medium supplemented with 10% fetal bovine serum (FBS). 4HPR was diluted from the stock solution into the growth medium immediately before addition to cell cultures. Control cultures received the same amount of DMSO as the treated cultures.
Antioxidants, enzyme inhibitors, mitochondrial respiratory inhibitors, and uncoupler
The following list includes the dierent reagents and the stock solutions that were prepared from them: catalase (Gorman et al., 1997; Oishi and Machida, 1997 ) 100 mg/ml in phosphate-buered saline (PBS); general antioxidants, pyrrolidine dithiocarbamate (PDTC) (Meyer et al., 1993; Schulze-Ostho et al., 1993) 10 mM in DMSO, nordihydroguaiaretic acid (NDGA) (Fedyk and Phipps, 1994; Goodman et al., 1994; Hunt and Fragonas, 1992) 50 mM in DMSO; NADPH oxidase inhibitor, diphenyleniodonium (DPI) (Trudel et al., 1991) 40 mM in PBS; xanthine/xanthine oxidase inhibitor, allopurinol (Caraceni et al., 1995; O'Donnell et al., 1995) 200 mM in PBS; phospholipase A 2 inhibitor, quinacrine (Henderson et al., 1989) 20 mM in water; MRC complex I inhibitor, rotenone (Henderson et al., 1989; Schulze-Ostho et al., 1992; Wolvetang et al., 1994) 10 mM in DMSO; MRC complex II inhibitor, thenoyltriuoroacetone (TTFA) (Berridge and Tan, 1993; SchulzeOstho et al., 1992) 500 mM in ethanol; MRC complex III inhibitor, antimycin A (mixture of antimycins, predominantly A 1 and A 3 ) (Schulze-Ostho et al., 1992; Turrens et al., 1985; Wolvetang et al., 1994) 20 mg/ml in DMSO. All the above reagents were purchased from Sigma Chemical Co. (St. Louis, MO, USA). The MRC complex IV inhibitor, sodium azide (Dawson et al., 1993; Schulze-Ostho et al., 1992) 1 M in water was from Fisher Scienti®c (Pittsburgh, PA, USA).
The uncoupler, carbonylcyanide m-chlorophenylhydrazone (CCCP) (Hu et al., 1992; Kluck et al., 1997; Zamzami et al., 1995) 50 mM in ethanol was from CalbiochemNovabiochem Int. (La Jolla, CA, USA).
DNA fragmentation assay
DNA fragmentation was analysed by quantitation of DNA solubilization induced by 4HPR using a modi®cation of the method of Higuchi et al. (1996) as described by Oridate et al. (1997) .
Detection of apoptosis and necrosis by¯uorescence microscopy
Apoptotic and necrotic cell deaths were distinguished by a modi®cation of the method described by Shimizu et al. (1996) and Ormerod et al. (1993) . After 24 h of culture with or without 4HPR, cells were incubated at 378C in the presence of 1 mg/ml of the bis-benzimidazole dye Hoechst 33342 (Sigma Chemical Co., St. Louis, MO, USA) for 10 min then cooled on ice. This dye is taken up more rapidly by apoptotic cells than by viable cells. It then binds to DNA and consequently the nuclei¯uoresce blue under UV illumination. The media containing¯oating cells were collected, centrifuged and the cell pellet was resuspended in PBS. The attached cells were washed with PBS, combined with thē oating cells, and the cells were then stained with 5 mg/ml propidium iodide (PI, Sigma). Viable cells and apoptotic cells retain membrane integrity, therefore, their nuclei do not stain with PI. In contrast, necrotic cells lose membrane integrity and their nuclei stain red with PI. The cells were analysed under a¯uorescence microscope with UV excitation and quantitative analysis was performed by counting at least 300 cells in several microscopic ®elds. Cells were categorized as viable (low blue and low red¯uorescence), necrotic (red nuclei), early apoptotic (fragmented blue nuclei) or late apoptotic (fragmented red nuclei) as described Shimizu et al. (1996) .
Assay of generation of reactive oxygen species
The net intracellular generation of ROS was measured by using the oxidation-sensitive¯uorescent dye 5,6-carboxy-2',7'-dichloro¯uorescin diacetate (DCFH-DA) (Molecular Probes, Eugene, OR, USA), as described previously (Oridate et al., 1997) . Three wells were used for each control or treatment analysis and the mean+s.d. were determined.
Assay for caspase-3-like protease
Caspase-3-like protease activity was measured by a modification of the method as described Higuchi et al. (1997) . C33A were treated with dierent agents for 16 h at 378C. At the end of the incubation, medium containing¯oating cells was collected and the attached cells were detached. Both cell populations were combined and centrifuged at 1000 g for 1 min. The pelleted cells were suspended in 1 ml lysis buer (1 mM dithiothreitol (DTT), 0.125 mM EDTA, 5% glycerol, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 1 mg/ml leupeptin, 1 mg/ml pepstatin, 1 mg/ml aprotinin, 1% Triton X-100 in 12.5 mM Tris-HCl buer, pH 7.0) at 48C and lysed by repeated freezing and thawing. Cell lysates were diluted with the reaction buer (1 mM DTT, 0.5 mM EDTA, 20% glycerol in 50 mM Tris-HCl buer, pH 7.0) and incubated at 378C in the presence of 20 mM of the caspase-3 substrate acetyl-AspGlu-Val-Asp-aminomethylcoumarin. The formation of thē uorescent aminomethylcoumarin product was measured at 2-min intervals at 460 nm after excitation at 360 nm using Fluoroskan II. Protein concentration was measured by a dyebinding assay using the Bio-Rad Protein Assay reagents (BioRad Laboratories, Hercules, CA, USA). Each assay was performed in triplicate and the results were calculated as the mean+s.e.m.
Detection of caspase-3 activation by Western blotting
Cytosolic extracts prepared as above and containing 20 mg protein were subjected to electrophoresis using 15% polyacrylamide slab gels in the presence of 0.1% sodium dodecylsulfate (SDS). The proteins were transferred electrophoretically (15 h, 25 mA) to PDVF membrane in a buer containing 25 mM Tris-HCl (pH 8.3), 192 mM glycine, and 20% (v/v) methanol. The nonspeci®c binding sites on the membrane were ®rst blocked with 5% (w/v) dried milk in 20 mM Tris-HCl (pH 8.0) containing 0.15 M NaCl and 0.1% (v/v) Tween 20 (TTBS) for 1 h at room temperature. After three washes with TTBS, the membrane was incubated with anity-puri®ed anti-caspase-3 antibody (Transduction Laboratories, Lexington, KY, USA) diluted 1 : 2000 in 1% (w/v) dried milk in TTBS for 1 h at room temperature. The membrane was then washed three times in TTBS, and incubated with rabbit anti-mouse IgG-horseradish peroxidase conjugate (DAKO, Denmark) diluted 1 : 2000 in 1% (w/ v) dried milk in TTBS for 1 h at room temperature. The membrane was then washed four times with TTBS, stained with enhanced chemiluminescence reagents from Amersham Inc. (UK) according to the supplier's instructions, dried and exposed brie¯y to X-ray ®lm.
Detection of cytochrome c release from mitochondria by Western blotting
Semi-con¯uent cultures of C33A cells were treated with dierent agents in 100-mm diameter plates at 378C for 12 h. At the end of the incubation, medium containing¯oating cells was collected and combined with the attached cells harvested by trypsinization. Cell suspension containing both the¯oating and the attached cells was subjected to centrifugation at 200 g for 5 min. After resuspension with 1 ml of buer I (sucrose 250 mM, 30 mM Tris, 1 mM EDTA, pH 7.7), the cells were transferred to microcentrifuge tubes and placed on ice. Then the cells were centrifuged in a microcentrifuge at 1000 g for 1 min. Thirty microliter of buer I supplemented with leupeptin 1 mg/ml, pepstatin 1 mg/ ml, and aprotinin 1 mg/ml were used to suspend the cells. The cells were then disrupted by homogenization on ice in a 0.3 ml Kontes dounce homogenizer (Kontes Glass Company) with 100 strokes of B pestle. The homogenate was subjected to centrifugation at 16 000 g for 1 min, and then the supernatant was collected and subjected to another centrifugation at 16 000 g for 30 min to obtain a cytosolic extract. Samples of the cytosolic extracts containing 20 mg protein were subjected to electrophoresis using 20% polyacrylamide slab gels in the presence of 0.1% SDS. After electrophoresis, the proteins were transferred electrophoretically to nitrocellulose membrane. After inhibiting nonspeci®c binding sites with dried milk, the membrane was incubated with anity-puri®ed anti-cytochrome c antibody 7H8.22C12 (Pharmingen, San Diego, CA, USA) diluted 1 : 2000 in 1% (w/v) dried milk in TTBS for 1 h at room temperature. The rest of the procedure was the same as that described above for caspase-3 detection.
Detection of MPT induction
Induction of MPT was evaluated by the decrease in mitochondrial transmembrane potential as described by Zamzami et al. (1995) . Brie¯y, after treatment with dierent agents, both the¯oating and the attached C33A cells were collected by trypsinization, then incubated with 40 nM 3,3'-dihexyloxacarbocyanine iodide (DiOC 6 ) for 15 min at 378C. A positive control for transmembrane potential loss was obtained by incubating C33A cells with the uncoupler CCCP (50 mM), a protonophore, which disrupts transmembrane potential. The cells were then analysed using a cytofluorimeter (Facscalibar, excitation at 488 nm; emission at 552 nm). At least 10 000 events were collected per sample. The suppression of transmembrane potential is represented as a shift of the¯uorescence peak to lower levels and the percentage of cells in the lower¯uorescence category was plotted in the graphs.
